STOCK TITAN

[Form 4] Doximity, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Doximity, Inc. (DOCS): A director reported multiple transactions on 10/10/2025. The insider exercised 5,000 stock options at an exercise price of $2.21, converted 5,000 shares of Class B Common Stock into Class A Common Stock, and sold 5,000 Class A shares at an average price of $70.84 pursuant to a Rule 10b5-1 trading plan adopted on February 26, 2025.

Following the transactions, the insider reported 19,839 shares of Class A Common Stock held directly. The filing notes that each share of Class B Common Stock is convertible into one share of Class A Common Stock at the holder’s option, and also outlines additional automatic conversion conditions.

Doximity, Inc. (DOCS): un direttore ha riportato molteplici transazioni il 10/10/2025. L'interno 5.000 opzioni su azioni a un prezzo di esercizio di $2,21, ha convertito 5.000 azioni di Classe B in Classe A, e ha venduto 5.000 azioni Classe A a un prezzo medio di $70,84 ai sensi di un piano di negoziazione Rule 10b5-1 adottato il 26 febbraio 2025.

Dopo le transazioni, l'insider ha riportato 19.839 azioni di Classe A detenute direttamente. La dichiarazione di deposito osserva che ogni azione di Classe B è convertibile in una azione di Classe A a scelta del detentore, e delinea anche ulteriori condizioni di conversione automatica.

Doximity, Inc. (DOCS): Un director informó de múltiples transacciones el 10/10/2025. El insider ejerció 5,000 opciones sobre acciones a un precio de ejercicio de $2.21, convirtió 5,000 acciones de Clase B en Clase A, y vendió 5,000 acciones Clase A a un precio medio de $70.84 conforme a un plan de negociación Rule 10b5-1 adoptado el 26 de febrero de 2025.

Tras las transacciones, el insider reportó 19,839 acciones de Clase A directamente. El expediente señala que cada acción de Clase B es convertible en una acción de Clase A a discreción del titular, y describe también condiciones automáticas de conversión adicionales.

Doximity, Inc. (DOCS): 이사는 2025년 10월 10일에 여러 거래를 보고했습니다. 내부자는 행사 가격이 2.21달러인 5,000주의 주식옵션을 행사했고, 5,000주의 클래스 B 보통주를 클래스 A 보통주로 전환했으며, 2025년 2월 26일에 채택된 Rule 10b5-1 거래 계획에 따라 평균가 70.84달러로 5,000주의 클래스 A 주식을 매매했습니다.

거래 후, 내부자는 직접 보유한 클래스 A 보통주 19,839주를 보고했습니다. 제출 문서는 클래스 B 보통주 한 주가 보유자의 선택에 따라 클래스 A 보통주 한 주로 전환될 수 있음을 밝히고, 추가 자동 전환 조건도 개요합니다.

Doximity, Inc. (DOCS): un administrateur/ directeur a rapporté plusieurs transactions le 10/10/2025. L'initié a exercé 5 000 options d'achat d'actions à un prix d'exercice de $2,21, converti 5 000 actions de Classe B en Classe A, et vendu 5 000 actions Classe A à un prix moyen de $70,84 conformément à un plan de trading Rule 10b5-1 adopté le 26 février 2025.

Suite aux transactions, l'initié a déclaré détenir directement 19 839 actions de Classe A. Le dépôt indique que chaque action de Classe B est convertible en une action de Classe A à l'option du détenteur, et décrit également des conditions additionnelles de conversion automatique.

Doximity, Inc. (DOCS): Ein Direktor meldete mehrere Transaktionen am 10.10.2025. Der Insider übte 5.000 Aktienoptionen zu einem Ausübungspreis von $2,21 aus, wandelte 5.000 Aktien der Klasse B in Klasse A um und verkaufte 5.000 Aktien der Klasse A zu einem durchschnittlichen Preis von $70,84 gemäß einem Rule 10b5-1-Handelsplan, der am 26. Februar 2025 angenommen wurde.

Nach den Transaktionen meldete der Insider direkt gehaltene 19.839 Aktien der Klasse A. Die Einreichung vermerkt, dass jede Aktie der Klasse B zu einer Aktie der Klasse A zu Optionsinhaber-Preis konvertibel ist, und umreißt außerdem weitere automatische Konvertierungsbedingungen.

Doximity, Inc. (DOCS): أبلغ عضو مجلس الإدارة عن عدة معاملات في 10/10/2025. مارس المطلّع 5,000 خيار أسهم بسعر ممارسة قدره $2.21, وحوّل 5,000 سهماً من Class B إلى Class A، وباع 5,000 سهماً من Class A بسعر متوسط $70.84 وفقاً لـ خطة تداول Rule 10b5-1 اعتمدت في 26 فبراير 2025.

بعد المعاملات، أعلن المطلّع عن امتلاكه مباشرةً لــ 19,839 سهماً من Class A Common Stock. تشير الوثيقة إلى أن كل سهم من Class B Common Stock قابل للتحويل إلى سهم واحد من Class A Common Stock وفق خيار الحائز، وتوضح أيضاً شروط تحويل تلقائي إضافية.

Doximity, Inc. (DOCS): 一位董事在2025/10/10报告了多笔交易。内部人以每股$2.21的行权价行使了5,000份股票期权,将 5,000股B类普通股转换为A类普通股,并依照在2025年2月26日通过的Rule 10b5-1交易计划以平均价格$70.84卖出5,000股A类股票。

交易结束后,内部人直接持有的A类普通股为19,839股。备案指出,每股B类普通股可由持有者选择转换为一股A类普通股,并且还概述了额外的自动转换条件。

Positive
  • None.
Negative
  • None.

Doximity, Inc. (DOCS): un direttore ha riportato molteplici transazioni il 10/10/2025. L'interno 5.000 opzioni su azioni a un prezzo di esercizio di $2,21, ha convertito 5.000 azioni di Classe B in Classe A, e ha venduto 5.000 azioni Classe A a un prezzo medio di $70,84 ai sensi di un piano di negoziazione Rule 10b5-1 adottato il 26 febbraio 2025.

Dopo le transazioni, l'insider ha riportato 19.839 azioni di Classe A detenute direttamente. La dichiarazione di deposito osserva che ogni azione di Classe B è convertibile in una azione di Classe A a scelta del detentore, e delinea anche ulteriori condizioni di conversione automatica.

Doximity, Inc. (DOCS): Un director informó de múltiples transacciones el 10/10/2025. El insider ejerció 5,000 opciones sobre acciones a un precio de ejercicio de $2.21, convirtió 5,000 acciones de Clase B en Clase A, y vendió 5,000 acciones Clase A a un precio medio de $70.84 conforme a un plan de negociación Rule 10b5-1 adoptado el 26 de febrero de 2025.

Tras las transacciones, el insider reportó 19,839 acciones de Clase A directamente. El expediente señala que cada acción de Clase B es convertible en una acción de Clase A a discreción del titular, y describe también condiciones automáticas de conversión adicionales.

Doximity, Inc. (DOCS): 이사는 2025년 10월 10일에 여러 거래를 보고했습니다. 내부자는 행사 가격이 2.21달러인 5,000주의 주식옵션을 행사했고, 5,000주의 클래스 B 보통주를 클래스 A 보통주로 전환했으며, 2025년 2월 26일에 채택된 Rule 10b5-1 거래 계획에 따라 평균가 70.84달러로 5,000주의 클래스 A 주식을 매매했습니다.

거래 후, 내부자는 직접 보유한 클래스 A 보통주 19,839주를 보고했습니다. 제출 문서는 클래스 B 보통주 한 주가 보유자의 선택에 따라 클래스 A 보통주 한 주로 전환될 수 있음을 밝히고, 추가 자동 전환 조건도 개요합니다.

Doximity, Inc. (DOCS): un administrateur/ directeur a rapporté plusieurs transactions le 10/10/2025. L'initié a exercé 5 000 options d'achat d'actions à un prix d'exercice de $2,21, converti 5 000 actions de Classe B en Classe A, et vendu 5 000 actions Classe A à un prix moyen de $70,84 conformément à un plan de trading Rule 10b5-1 adopté le 26 février 2025.

Suite aux transactions, l'initié a déclaré détenir directement 19 839 actions de Classe A. Le dépôt indique que chaque action de Classe B est convertible en une action de Classe A à l'option du détenteur, et décrit également des conditions additionnelles de conversion automatique.

Doximity, Inc. (DOCS): Ein Direktor meldete mehrere Transaktionen am 10.10.2025. Der Insider übte 5.000 Aktienoptionen zu einem Ausübungspreis von $2,21 aus, wandelte 5.000 Aktien der Klasse B in Klasse A um und verkaufte 5.000 Aktien der Klasse A zu einem durchschnittlichen Preis von $70,84 gemäß einem Rule 10b5-1-Handelsplan, der am 26. Februar 2025 angenommen wurde.

Nach den Transaktionen meldete der Insider direkt gehaltene 19.839 Aktien der Klasse A. Die Einreichung vermerkt, dass jede Aktie der Klasse B zu einer Aktie der Klasse A zu Optionsinhaber-Preis konvertibel ist, und umreißt außerdem weitere automatische Konvertierungsbedingungen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Benjamin Regina M.

(Last) (First) (Middle)
C/O DOXIMITY, INC.
500 THIRD STREET

(Street)
SAN FRANCISCO CA 94107

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/10/2025 C(1) 5,000 A (1) 24,839 D
Class A Common Stock 10/10/2025 S(2) 5,000 D $70.84 19,839 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $2.21 10/10/2025 M 5,000 (3) 09/01/2030 Class B Common Stock(4) 5,000 $0 351,138 D
Class B Common Stock (4) 10/10/2025 M 5,000 (4) (4) Class A Common Stock 5,000 $0 5,000 D
Class B Common Stock (4) 10/10/2025 C(1) 5,000 (4) (4) Class A Common Stock 5,000 $0 0 D
Explanation of Responses:
1. Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.
2. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025.
3. The stock option vested in 36 equal monthly installments after September 2, 2020, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on September 2, 2020.
4. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.
Remarks:
/s/ John T. Vaughan, Attorney-in-Fact 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Doximity Inc

NYSE:DOCS

DOCS Rankings

DOCS Latest News

DOCS Latest SEC Filings

DOCS Stock Data

12.61B
133.28M
2.29%
90.53%
2.51%
Health Information Services
Services-computer Programming Services
Link
United States
SAN FRANCISCO